Journal of Cardiac Failure
Volume 14, Issue 1 , Pages 6-8 , February 2008

Fluid Removal: Are We Any Wiser?

References 

  1. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Constanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale design and preliminary observations from the Acute Decompensated Heart Failure National Registry (ADHERE®). Am Heart J. 2005;149:209–216
  2. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJV, Granger CB, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116:1482–1487
  3. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J. 2000;140:840–847
  4. Weber KT. Furosemide in the long term management of heart failure: the good, the bad and the uncertain. J Am Coll Cardiol. 2004;44:1308–1310
  5. McCurley J, Hanlon S, Shao-kui W, Wedam E, Michalski M, Haigney M. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol. 2004;44:1301–1307
  6. Philbin EF, Cotto M, Rocco TA, Jenkins PL. Association between diuretic use, clinical response and death in acute heart failure. Am J Cardiol. 1997;80:519–523
  7. Neuberg GW, Miller AB, O'Connor CM, Belkin RN, Carson PE, Cropp AB, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J. 2002;144:31–38
  8. Eshaghian S, Howrich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006;97:1759–1764
  9. Faris R, Flather MD, Purcell H, Poole-Wilson PA, Coats AJS. Diuretics for heart failure. Issue 1. art No.: CD003838 Cochrane Database of Systematic Reviews. 2006;
  10. Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA. 2007;297:1319–1331
  11. Udelson JE, Orlandi C, Ouyang J, Krasa H, Zimmer CA, Frivoid G, et al. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: The ECLIPSE international multicenter randomized, placebo-controlled trial. J Card Fail. 2007;13:793
  12. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114:625–630
  13. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116:1549–1554
  14. Gerhardt RE, Abdullah AM, Mach SJ, Hudson JB. Isolated ultrafiltration in the treatment of refractory congestive heart failure. Arch Intern Med. 1979;139:358–359
  15. Bourge RC, Tallaj JA. Ultrafiltration a new approach toward mechanical diuresis in heart failure. J Am Coll Cardiol. 2005;46:2052–2053
  16. Agostoni P, Marenzi G, Lauri G, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency failure of furosemide to provide the same result. Am J Med. 1994;96:191–199
  17. Constanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675–683
  18. Schrier RW. Role of diminished renal function in cardiovascular mortality marker or pathogenetic factor?. J Am Coll Cardiol. 2006;47:1–8
  19. Libetta C, Sepe V, Zucchi M, Pisacco P, Cosmai L. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant. 2007;22:2013–2019
  20. Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, et al. A randomized, controlled trial of the renal effect of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail. 2008;14:1–5
  21. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail. 2003;9:13–25
  22. Shlipak MG, Chertow GC, Massie BM. Beware the rising creatinine level. J Card Fail. 2003;9:26–28
  23. Gottlieb SS, Brater DC, Thomas I, Havranck E, Bourge R, Goldman S, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;105:1348–1353
  24. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol. 2001;38:963–968
  25. Boyle A, Sobotka PA. Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail. 2006;12:247–249
  26. Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail. 2000;2:305–313
  27. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007;50:1551–1560
  28. Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail. 2007;13:609–617

PII: S1071-9164(07)01152-9

doi: 10.1016/j.cardfail.2007.11.007

Journal of Cardiac Failure
Volume 14, Issue 1 , Pages 6-8 , February 2008

Article Tools